Follow
Marín-Béjar Oskar
Marín-Béjar Oskar
IGTP
Verified email at igtp.cat
Title
Cited by
Cited by
Year
Toward minimal residual disease-directed therapy in melanoma
F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ...
Cell 174 (4), 843-855. e19, 2018
5702018
PintlincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2
O Marín-Béjar, FP Marchese, A Athie, Y Sánchez, J González, V Segura, ...
Genome biology 14, 1-17, 2013
2692013
Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature
Y Sánchez, V Segura, O Marín-Béjar, A Athie, FP Marchese, J González, ...
Nature communications 5 (1), 5812, 2014
2072014
The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element
O Marín-Béjar, AM Mas, J González, D Martinez, A Athie, X Morales, ...
Genome biology 18, 1-15, 2017
1852017
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
O Marin-Bejar, A Rogiers, M Dewaele, J Femel, P Karras, J Pozniak, ...
Cancer Cell 39 (8), 1135-1149. e8, 2021
892021
A long noncoding RNA regulates sister chromatid cohesion
FP Marchese, E Grossi, O Marín-Béjar, SK Bharti, I Raimondi, J González, ...
Molecular cell 63 (3), 397-407, 2016
892016
RNA pulldown protocol for in vitro detection and identification of RNA-associated proteins
O Marín-Béjar, M Huarte
Regulatory Non-Coding RNAs: Methods and Protocols, 87-95, 2015
612015
Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia
I Vázquez, M Maicas, J Cervera, X Agirre, O Marin-Béjar, N Marcotegui, ...
haematologica 96 (10), 1448, 2011
612011
Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion
A Athie, FP Marchese, J González, T Lozano, I Raimondi, PK Juvvuna, ...
Journal of Cell Biology 219 (9), 2020
422020
Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming
A Janiszewski, I Talon, J Chappell, S Collombet, J Song, N De Geest, ...
Genome research 29 (10), 1659-1672, 2019
402019
Long noncoding RNAs: from identification to functions and mechanisms
O Marín-Béjar, M Huarte
Advances in Genomics and Genetics, 257-274, 2015
242015
The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma
G Aldave, M Gonzalez-Huarriz, A Rubio, JP Romero, D Ravi, B Miñana, ...
Neuro-oncology 20 (7), 930-941, 2018
232018
CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance
A Gautron, L Bachelot, M Aubry, D Leclerc, AM Quéméner, S Corre, ...
EMBO Molecular Medicine 13 (5), e13466, 2021
182021
Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to targeted therapy in melanoma
S Diazzi, A Baeri, J Fassy, M Lecacheur, O Marin‐Bejar, CA Girard, ...
EMBO Molecular Medicine 14 (3), e15295, 2022
112022
A neural crest stem cell-like state drives nongenetic resistance to targeted therapy in melanoma
O Marin-Bejar, A Rogiers, M Dewaele, J Femel, P Karras, J Pozniak, ...
bioRxiv, 2020.12. 15.422929, 2020
42020
Blockade of pro-fibrotic response mediated by the miR-143/-145 cluster prevents targeted therapy-induced phenotypic plasticity and resistance in melanoma
S Diazzi, A Baeri, J Fassy, M Lecacheur, O Marin-Bejar, CA Girard, ...
bioRxiv, 2021.07. 02.450838, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–16